[1]
“Comparison of the Effects of Solifenacin Succinate for the Treatment of Overactive Bladder with Extended Release Tolterodine”, Bang J Urology, vol. 23, no. 1, pp. 76–81, Nov. 2020, doi: 10.3329/bju.v23i1.50295.